$7.38
-0.160 (-2.12%)
At Close: Jun 03, 2026
Corcept (CORT) Posts OS Data from Phase II Ovarian Cancer Study
01:51pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Corcept (CORT) posts overall survival data from a phase II study evaluating relacorilant plus nab-paclitaxel for treating recurrent platinum-resistant ovarian cancer.
Hot Marijuana Penny Stocks Under $1 To Watch Ahead Of MORE Act Vote
01:31pm, Friday, 25'th Mar 2022 PennyStocks
Marijuana penny stocks to watch right now.
The post Hot Marijuana Penny Stocks Under $1 To Watch Ahead Of MORE Act Vote appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks
Hot Marijuana Penny Stocks Under $1 To Watch Ahead Of MORE Act Vote
09:31am, Friday, 25'th Mar 2022
Marijuana penny stocks to watch right now. The post Hot Marijuana Penny Stocks Under $1 To Watch Ahead Of MORE Act Vote appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks
AlloVir (ALVR) Begins Study to Prevent Six Viral Infections
01:56pm, Wednesday, 23'rd Mar 2022 Zacks Investment Research
AlloVir (ALVR) starts a phase III study on its lead candidate, posoleucel, for the prevention of life-threatening viral infections from six common viruses. Shares up.
Zacks.com featured highlights include Carter's, Target Hospitality, iQIYI, The Buckle, and Corbus Pharmaceuticals
02:12pm, Friday, 18'th Mar 2022 Zacks Investment Research
Carter's, Target Hospitality, iQIYI, The Buckle, and Corbus Pharmaceuticals are part of today's Screen of the Week blog.
Ride on Rising P/E Investing With These 5 Top-Ranked Stocks
02:41pm, Thursday, 17'th Mar 2022 Zacks Investment Research
Want to try an out-of-the-box approach? Tap five stocks including CRI, TH, IQ, BKE and CRBP with increasing P/E ratios.
Ride on Rising P/E Investing With These 5 Top-Ranked Stocks
12:02pm, Thursday, 17'th Mar 2022
Want to try an out-of-the-box approach? Tap five stocks including CRI, TH, IQ, BKE and CRBP with increasing P/E ratios.
Is it the Right Time to Add Mednax (MD) Stock to Your Kitty?
03:54pm, Wednesday, 16'th Mar 2022 Zacks Investment Research
Growing revenues, numerous acquisitions, diversified care network and adequate cash generation abilities are likely to continue driving Mednax (MD).
Cannabis Stock Movers For March 14, 2022
09:31pm, Monday, 14'th Mar 2022 Benzinga
GAINERS: Leviathan Natural Prods (OTC: LVCNF ) shares closed up 10.17% at $0.61 Marrone Bio Innovations (NASDAQ: MBII ) shares closed up 7.39% at $0.81 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed up 7.17% at $0.43 Charlottes Web Holdings (OTC: CWBHF ) shares closed up 5.88% at $1.08 World Acceptance (NASDAQ: WRLD ) shares closed up 4.48% at $171.03 Urban-gro (NASDAQ: UGRO ) shares closed up 3.02% at $9.88 LOSERS: Origin Agritech (NASDAQ: SEED ) shares closed down 16.05% at $8.68 ReneSola (NYSE: SOL ) shares closed down 12.32% at $5.55 Greenlane Hldgs (NASDAQ: Full story available on Benzinga.com
Cannabis Stock Movers For March 11, 2022
09:30pm, Friday, 11'th Mar 2022 Benzinga
GAINERS: Heritage Cannabis Holding (OTC: HERTF ) shares closed up 47.50% at $0.06 Origin Agritech (NASDAQ: SEED ) shares closed up 7.93% at $10.34 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed up 5.00% at $0.40 MedMen Enterprises (OTC: MMNFF ) shares closed up 3.94% at $0.12 LOSERS: Nine Energy Service (NYSE: NINE ) shares closed down 22.22% at $3.29 MGC Pharmaceuticals (OTC: MGCLF ) shares closed down 15.84% at $0.02 RIV Capital (OTC: CNPOF ) shares closed down 7.58% at $1.00 22nd Century Group (NASDAQ: XXII ) shares closed down 7.30% at … Full story available on Benzinga.com
Corbus Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference
01:05pm, Friday, 11'th Mar 2022 PR Newswire
NORWOOD, Mass., March 11, 2022 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, today announcing that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat at the Oppenheimer 32nd…
Corbus Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference
08:05am, Friday, 11'th Mar 2022
NORWOOD, Mass., March 11, 2022 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, today announcing that Yuval Cohen, Ph.D.
Lumpy Stock: Abeona Therapeutics Inc. (NASDAQ:ABEO), Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)
06:42am, Friday, 11'th Mar 2022 Stock Equity
Abeona Therapeutics Inc. (NASDAQ:ABEO) with the stream of -1.83% also noticed, India Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) encountered a rapid change of 3.54% in the last hour of Thursday’s trading … The post Lumpy Stock: Abeona Therapeutics Inc. (NASDAQ:ABEO), Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) appeared first on Stocks Equity .
Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates
11:15pm, Tuesday, 08'th Mar 2022 Zacks Investment Research
Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -2.70% and 12.98%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the sto
Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) Stock: Will It Keep Climbing Higher?
03:30pm, Tuesday, 08'th Mar 2022 Marketing Sentinel
In the last trading session, 1.33 million shares of the Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) were traded, and its beta was 1.79. Most recently the company’s share price was $0.32, and it changed around -$0.02 or -5.95% from the last close, which brings the market valuation of the company to $42.08M. CRBP currently trades at … Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) Stock: Will It Keep Climbing Higher? Read More »
Sign In
Buy CRBP